Literature DB >> 26095663

Common hepatic artery as inflow in kidney transplantation.

A Duprey1, B Chavent1, N Maillard2, C Mariat2, E Alamartine2, J N Albertini1, J P Favre1, X Barral1.   

Abstract

Kidney transplantation originating from the hepatic artery has not previously been reported. Herein, we report a third kidney transplantation with the common hepatic artery as inflow. A 62-year-old male with chronic renal failure due to polycystic kidney disease was proposed to a third kidney transplantation. CT-scan showed diffuse calcification of the aorto-iliac axis and the splenic artery. The common hepatic artery was the only artery suitable for anastomosis and as such was chosen as the inflow for retransplantation. The operation was performed through a right subcostal laparotomy. A saphenous bypass was interposed between the common hepatic artery and the graft, then the renal vein was anastomosed to the suprarenal inferior vena cava. Duration of warm ischemia was 27 min. Postoperative course was complicated with delayed graft function of 17 days and pulmonary infection. Patient was discharged at day 30. With a follow-up of 40 months, serum creatinine level and eGFR are, respectively, 191 µmol/L and 32 mL/min. Hepato-renal bypass technique can be used in kidney retransplantation when patient anatomy is not compatible with other classical options. © Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Cardiovascular disease; retransplantation

Mesh:

Year:  2015        PMID: 26095663     DOI: 10.1111/ajt.13340

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  2 in total

Review 1.  Tigecycline-induced acute pancreatitis in a renal transplant patient: a case report and literature review.

Authors:  Jinwen Lin; Rending Wang; Jianghua Chen
Journal:  BMC Infect Dis       Date:  2018-05-02       Impact factor: 3.090

Review 2.  Acute pancreatitis caused by tigecycline: A case report and literature review.

Authors:  Peng-Fei Wang; Hong Zou; Ji-Hong Zhu; Fang-E Shi
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.